2020 Europe Hemostasis Analyzers and Reagents: France, Germany, Italy, Spain, UK-Supplier Shares and Strategies, Sales Segment Forecasts, Competitive Intelligence, Technology and Instrumentation Review, Opportunities for Suppliers
Summary
This comprehensive five-country report contains 500 pages, 120 tables, and is designed to help current suppliers and potential market entrants identify and evaluate business opportunities emerging in the European coagulation testing market during the next five years.
The report explores business and technological trends in France, Germany, Italy, Spain, and the UK; provides estimates of the test volume, as well as sales and market shares of leading competitors; compares features of major analyzers; profiles leading market players; and identifies specific product and business opportunities facing instrument and consumable suppliers during the next five years.
Coagulation Tests
Activated Clotting Time (ACT) (1), Activated Protein C Resistance, Activated PTT (APTT), Alpha 2-Antiplasmin, Antithrombin III, Bleeding Time, D-Dimer, Factor II, Factor V, Factor V Leiden, Factor VII, Factor VIII, Factor IX, Factor Ixa, Factor X (Stuart Factor), Factor Xa, Factor XI, Factor XII, Factor XIII, Fibrin Degradation Products, Fibrinogen, Fletcher Factor/Pre-Kallikrein Factor Activation, Heparin/Anti-Factor Xa, Heparin-Induced Thrombocytopenia, Plasmin, Plasminogen, Plasminogen Activator Inhib., Platelet Function/Aggregation, Protein C, Protein S, Prothrombin Mutation, Prothrombin Time (PT), Reptilase Time, Thrombin Time, Von Willebrand's Factor Fav/Ag, and others.
Geographic Coverage
France, Germany, Italy, Spain, UK
Sales and Market Share Analysis
Sales and market shares of major instrument and reagent suppliers.
Competitive Assessments
Extensive strategic profiles of major suppliers and emerging market entrants.
Market Segmentation Analysis
This comprehensive five-country report contains 500 pages, 120 tables, and is designed to help current suppliers and potential market entrants identify and evaluate business opportunities emerging in the European coagulation testing market during the next five years.
The report explores business and technological trends in France, Germany, Italy, Spain, and the UK; provides estimates of the test volume, as well as sales and market shares of leading competitors; compares features of major analyzers; profiles leading market players; and identifies specific product and business opportunities facing instrument and consumable suppliers during the next five years.
Coagulation Tests
Activated Clotting Time (ACT) (1), Activated Protein C Resistance, Activated PTT (APTT), Alpha 2-Antiplasmin, Antithrombin III, Bleeding Time, D-Dimer, Factor II, Factor V, Factor V Leiden, Factor VII, Factor VIII, Factor IX, Factor Ixa, Factor X (Stuart Factor), Factor Xa, Factor XI, Factor XII, Factor XIII, Fibrin Degradation Products, Fibrinogen, Fletcher Factor/Pre-Kallikrein Factor Activation, Heparin/Anti-Factor Xa, Heparin-Induced Thrombocytopenia, Plasmin, Plasminogen, Plasminogen Activator Inhib., Platelet Function/Aggregation, Protein C, Protein S, Prothrombin Mutation, Prothrombin Time (PT), Reptilase Time, Thrombin Time, Von Willebrand's Factor Fav/Ag, and others.
Geographic Coverage
France, Germany, Italy, Spain, UK
Sales and Market Share Analysis
Sales and market shares of major instrument and reagent suppliers.
Competitive Assessments
Extensive strategic profiles of major suppliers and emerging market entrants.
Market Segmentation Analysis
- Comprehensive market segmentation analysis, including:
- Hospitals
- Commercial/Private Laboratories
- Physician Offices
- Ambulatory Care Centers
- Test volume forecasts for over 40 major procedures, by country and market segment.
- Review of established and emerging procedures.
- Comparison of automated and semi-automated analyzers from Diagnostica Stago, Helena, IL, Siemens, Sysmex and other suppliers.
- Analysis of current and emerging technologies and their potential market applications.
- Comprehensive lists of companies developing or marketing new technologies and products by test.
- Product development and business expansion opportunities with significant market appeal.
- “Ideal” product models with tentative prices and operating characteristics.
- Alternative market penetration strategies for instrument and reagent suppliers.
- Potential market entry barriers and risks.
More Publications
Europe Clinical Chemistry Reagents and Analyzers Market 2021: A 31-Country Analysis-Supplier Shares and Strategies, Volume and Sales Segment Forecasts, Technology and Instrumentation Review
US$ 41,850.00
May 2017
1440 pages
2019-2023 Competing in the Europe Hematology and Flow Cytometry Market: France, Germany, Italy, Spain, UK-Analyzer and Consumable Supplier Shares, Segment Forecasts by Test and Country, Competitive Intelligence, Emerging Technologies, Instrumentation, Opportunities for Suppliers
US$ 17,500.00
March 2019
450 pages
2024 Europe Hemostasis Diagnostic Analyzers and Reagent Market Shares and Segment Forecasts: A 31-Country Analysis-Supplier Strategies, Emerging Technologies, Latest Instrumentation and Growth Opportunities
US$ 24,500.00
June 2020
615 pages
